Rob W. Reistetter

Founder at

Iron Path Capital LP

Finance

Consumer Services

Health Services

Profile

Rob W.
Reistetter is the founder of Iron Path Capital LP, which is founded in 2021, where he holds the title of Managing Partner.
He currently holds the position of Director at both Versant Diagnostics and Emergence Health Holdings.
In the past, he worked as an Analyst at JPMorgan Chase & Co., as a Principal at Quad-C Management, Inc. from 2007 to 2021, and as a Research Analyst at JLL Partners, Inc. He received his undergraduate degree from Ithaca College in 1999 and his MBA from Harvard Business School in 2007.

Rob W. Reistetter active positions

Companies	Position	Start
Iron Path Capital LP Iron Path Capital LP Investment ManagersFinance Iron Path Capital invests in lower middle market companies located in the United States. The firm focuses on healthcare and specialty industrials businesses with USD 5 - 15 million in EBITDA. It participates in buyout transactions.	Founder	2021-03-31
Emergence Health Holdings Emergence Health Holdings Medical/Nursing ServicesHealth Services Provides urgent healthcare services	Director/Board Member	-
Versant Diagnostics Versant Diagnostics Medical/Nursing ServicesHealth Services Operates as a clinical laboratory for healthcare industry	Director/Board Member	-

All active positions of Rob W. Reistetter

Former positions of Rob W. Reistetter

Companies	Position	End
Quad-C Management, Inc. Quad-C Management, Inc. Investment ManagersFinance Quad-C invests in middle market companies located in North America with an enterprise value between USD 100 - 500 million. The firm focuses on on a broad range of sectors and industries. It provides financing for buyout and growth stage capital requirements with an investment size of USD 50 - 150 million. The firm also acquires majority interests.	Private Equity Analyst	2021-03-31
JLL Partners, Inc. JLL Partners, Inc. Investment ManagersFinance JLL Partners invests in middle-market companies located in the US. The firm focuses on a broad range of sectors and industries. It provides financing for buyout and growth stage capital requirements with an investment size ranging from USD75 to 200 million and seeks controlling interest.	Private Equity Analyst	2005-12-14
JPMORGAN CHASE & CO.	Corporate Officer/Principal	2005-01-26

See the detail of Rob W. Reistetter's experience

Education of Rob W. Reistetter

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Rob W. Reistetter's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	8
JPMorgan Chase & Co. JPMorgan Chase & Co. Major BanksFinance Provides banking, asset management, investment banking, credit card and mortgage services	Finance
Quad-C Management, Inc. Quad-C Management, Inc. Investment ManagersFinance Quad-C invests in middle market companies located in North America with an enterprise value between USD 100 - 500 million. The firm focuses on on a broad range of sectors and industries. It provides financing for buyout and growth stage capital requirements with an investment size of USD 50 - 150 million. The firm also acquires majority interests.	Finance
JLL Partners, Inc. JLL Partners, Inc. Investment ManagersFinance JLL Partners invests in middle-market companies located in the US. The firm focuses on a broad range of sectors and industries. It provides financing for buyout and growth stage capital requirements with an investment size ranging from USD75 to 200 million and seeks controlling interest.	Finance
Ithaca College Ithaca College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Harvard Business School Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Iron Path Capital LP Iron Path Capital LP Investment ManagersFinance Iron Path Capital invests in lower middle market companies located in the United States. The firm focuses on healthcare and specialty industrials businesses with USD 5 - 15 million in EBITDA. It participates in buyout transactions.	Finance
Versant Diagnostics Versant Diagnostics Medical/Nursing ServicesHealth Services Operates as a clinical laboratory for healthcare industry	Health Services
Emergence Health Holdings Emergence Health Holdings Medical/Nursing ServicesHealth Services Provides urgent healthcare services	Health Services